Newsig · Investing.com
Berenberg upgrades Eli Lilly stock rating on obesity drug strength
Market context: LLY: Berenberg upgraded Eli Lilly's rating, citing strength in its obesity drug franchise. Upgrade signals continued bullish sentiment on Lilly's obesity pipeline; modestly bullish.
Why it matters
LLY (Eli Lilly) · Why linked: Berenberg upgraded Eli Lilly's rating, citing strength in its obesity drug franchise. Market context: Upgrade signals continued bullish sentiment on Lilly's obesity pipeline; modestly bullish.
Reaction tracking
A completed 24-hour reaction record is not available for this story yet. Newsig only publishes measured price movement when the required market data is present.
Curated by Newsig — News in. Signal out.
How the reaction data is measured · Editorial policy